3-(2-chloro-4-fluorophenoxy)-N-(3-ethylsulfonylphenyl)-6-(trifluoromethyl)pyridazine-4-carboxamide
C20H14ClF4N3O4S — CID 170556611
Data last refreshed: (MolForge compound catalog, from PubChem)
About 3-(2-chloro-4-fluorophenoxy)-N-(3-ethylsulfonylphenyl)-6-(trifluoromethyl)pyridazine-4-carboxamide
3-(2-chloro-4-fluorophenoxy)-N-(3-ethylsulfonylphenyl)-6-(trifluoromethyl)pyridazine-4-carboxamide (PubChem CID 170556611) has the molecular formula C20H14ClF4N3O4S and a molecular weight of 503.86 g/mol. Its IUPAC name is 3-(2-chloro-4-fluorophenoxy)-N-(3-ethylsulfonylphenyl)-6-(trifluoromethyl)pyridazine-4-carboxamide.
Molecular Properties
| Compound Name | 3-(2-chloro-4-fluorophenoxy)-N-(3-ethylsulfonylphenyl)-6-(trifluoromethyl)pyridazine-4-carboxamide |
|---|---|
| PubChem CID | 170556611 |
| Molecular Formula | C20H14ClF4N3O4S |
| Molecular Weight | 503.86 g/mol |
| Exact Mass | 503.03 |
| IUPAC Name | 3-(2-chloro-4-fluorophenoxy)-N-(3-ethylsulfonylphenyl)-6-(trifluoromethyl)pyridazine-4-carboxamide |
| SMILES | CCS(=O)(=O)c1cccc(NC(=O)c2cc(C(F)(F)F)nnc2Oc2ccc(F)cc2Cl)c1 |
| InChI | InChI=1S/C20H14ClF4N3O4S/c1-2-33(30,31)13-5-3-4-12(9-13)26-18(29)14-10-17(20(23,24)25)27-28-19(14)32-16-7-6-11(22)8-15(16)21/h3-10H,2H2,1H3,(H,26,29) |
| InChIKey | VGUXMZIEAZNADI-UHFFFAOYSA-N |
| XLogP | 5.13 |
| TPSA | 98.25 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 33 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 503.86 |
| LogP ≤ 5 | 5.13 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 170556611 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.